Skip to main content
Logo
European Innovation Council
  • private sector

XENOTHERA

 Treat severe cases of infection at COV with XAV-19

XENOTHERA Logo

Overview

Description

The company develops innovative glyco-humanized antibody therapies for immunology, oncology, transplantation and infectious diseases.

Website
Country
  • France
Sector
  • Health Biotechnology